Search

Your search keyword '"Kosinski CM"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Kosinski CM" Remove constraint Author: "Kosinski CM"
50 results on '"Kosinski CM"'

Search Results

1. Suicidal ideation in a European Huntington's disease population

2. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

3. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease

4. β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease

5. Discrepancies in reporting the CAG repeat lengths for Huntington's disease

12. Regulation of self-renewal and differentiation by the intestinal stem cell niche.

13. [Treatment of mental disorders in patients with Parkinson's disease].

14. Transdermal dopaminergic stimulation with rotigotine in Parkinsonian akinetic crisis.

15. High rate of restenosis after carotid artery stenting in patients with high-grade internal carotid artery stenosis. Medium-term follow-up.

16. Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice.

17. Cerebral kinetics of the dopamine D(2) receptor ligand [(123)I]IBZM in mice.

18. Management of an occluding macro-embolus at the carotid bifurcation.

19. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.

20. [Chorea. Causes, diagnosis, and therapy].

21. Myopathy as a first symptom of Huntington's disease in a Marathon runner.

22. High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo.

23. Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease.

24. Rapid geographical clustering of wound botulism in Germany after subcutaneous and intramuscular injection of heroin.

25. Neural cell adhesion molecule L1-transfected embryonic stem cells promote functional recovery after excitotoxic lesion of the mouse striatum.

26. Non-traumatic cortical subarachnoid haemorrhage: diagnostic work-up and aetiological background.

27. Do normal D-dimer levels reliably exclude cerebral sinus thrombosis?

28. [Theodor Schwann].

29. Eyelid oedema and headache.

30. [Hypokalemic paralysis with thyrotoxicosis].

31. [Fulminant meningoencephalitis associated with Mycoplasma pneumoniae infection in adults. Aggressive treatment enabled a good outcome].

32. The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease.

33. Warfarin prophylaxis in the antiphospholipid antibody syndrome.

34. Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease.

35. A case of gliosarcoma appearing as ischaemic stroke.

36. Huntington's disease transgenic mice are resistant to global cerebral ischemia.

37. Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease.

38. Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus.

39. [Glutamate antagonists in neurology].

40. Intranuclear inclusions in subtypes of striatal neurons in Huntington's disease transgenic mice.

41. Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia.

42. [Huntington chorea. Animal models reveal new hypotheses for pathophysiology and therapy].

43. Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease.

44. Evidence for a non-orthostatic origin of orthostatic tremor.

45. Expression of metabotropic glutamate receptor 1 isoforms in the substantia nigra pars compacta of the rat.

46. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.

47. Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex.

48. Expression of N-methyl-D-aspartate receptor subunit mRNA in the human brain: mesencephalic dopaminergic neurons.

49. Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: striatum and globus pallidus.

50. Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons.

Catalog

Books, media, physical & digital resources